- Home
- MEDP vs HMY Comparison
MEDP vs HMY Comparison
Compare MEDP & HMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- HMY
- Stock Information
- Founded
- MEDP 1992
- HMY 1950
- Country
- MEDP United States
- HMY South Africa
- Employees
- MEDP N/A
- HMY N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- HMY Precious Metals
- Sector
- MEDP Health Care
- HMY Basic Materials
- Exchange
- MEDP Nasdaq
- HMY Nasdaq
- Market Cap
- MEDP 8.3B
- HMY 9.2B
- IPO Year
- MEDP 2016
- HMY N/A
- Fundamental
- Price
- MEDP $294.90
- HMY $14.61
- Analyst Decision
- MEDP Hold
- HMY Sell
- Analyst Count
- MEDP 10
- HMY 2
- Target Price
- MEDP $343.22
- HMY $6.60
- AVG Volume (30 Days)
- MEDP 333.7K
- HMY 4.7M
- Earning Date
- MEDP 07-21-2025
- HMY 01-01-0001
- Dividend Yield
- MEDP N/A
- HMY 1.18%
- EPS Growth
- MEDP 33.36
- HMY 16.30
- EPS
- MEDP 13.09
- HMY 0.88
- Revenue
- MEDP $2,156,580,000.00
- HMY $3,553,951,394.00
- Revenue This Year
- MEDP $5.59
- HMY $23.09
- Revenue Next Year
- MEDP $3.46
- HMY $14.74
- P/E Ratio
- MEDP $22.53
- HMY $15.84
- Revenue Growth
- MEDP 9.87
- HMY 16.84
- 52 Week Low
- MEDP $250.05
- HMY $7.97
- 52 Week High
- MEDP $459.77
- HMY $18.77
- Technical
- Relative Strength Index (RSI)
- MEDP 46.73
- HMY 46.68
- Support Level
- MEDP $293.51
- HMY $14.33
- Resistance Level
- MEDP $302.32
- HMY $14.87
- Average True Range (ATR)
- MEDP 9.27
- HMY 0.44
- MACD
- MEDP -0.39
- HMY -0.08
- Stochastic Oscillator
- MEDP 33.56
- HMY 42.67
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.